BIA
UTHR icon

Bell Investment Advisors’s United Therapeutics UTHR Stock Holding History

Bell Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Hold
41
– – ﹤0.01% 441
2026
Q1 		$24.3K Sell
41
-2
-5% -$996 ﹤0.01% 404
2025
Q4 		$21K Buy
43
+15
+54% +$6.99K ﹤0.01% 438
2025
Q3 		$11.7K Sell
28
-18
-39% -$6.05K ﹤0.01% 578
2025
Q2 		$13.2K Buy
46
+9
+24% +$2.69K ﹤0.01% 567
2025
Q1 		$11.4K Hold
37
– – ﹤0.01% 552
2024
Q4 		$13.1K Buy
37
+1
+3% +$368 ﹤0.01% 506
2024
Q3 		$12.9K Hold
36
– – ﹤0.01% 525
2024
Q2 		$11.5K Buy
36
+8
+29% +$2.12K ﹤0.01% 564
2024
Q1 		$6.43K Sell
28
-10
-26% -$2.26K ﹤0.01% 788
2023
Q4 		$8.36K Buy
38
+8
+27% +$1.84K ﹤0.01% 630
2023
Q3 		$6.78K Buy
30
+4
+15% +$921 ﹤0.01% 662
2023
Q2 		$5.74K Sell
26
-12
-32% -$2.66K ﹤0.01% 745
2023
Q1 		$8.51K Buy
38
+3
+9% +$740 ﹤0.01% 546
2022
Q4 		$9.73K Buy
35
+2
+6% +$505 ﹤0.01% 495
2022
Q3 		$7K Sell
33
-3
-8% -$671 ﹤0.01% 556
2022
Q2 		$8K Buy
+36
New +$7.32K ﹤0.01% 525
2021
Q4 		$5K Buy
21
+6
+40% +$1.18K ﹤0.01% 808
2021
Q3 		$3K Buy
+15
New +$2.96K ﹤0.01% 982

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bell Investment Advisors's UTHR Position: Q2 2026 in Review

Bell Investment Advisors held its United Therapeutics (UTHR) position steady in Q2 2026 at 41 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Bell Investment Advisors first reported a position in UTHR in Q3 2021 and has held it in 19 quarters since. The position peaked at $24.3K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bell Investment Advisors held 41 shares of United Therapeutics worth $22.2K as of Q2 2026.
  • Bell Investment Advisors left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #441 holding.
  • Bell Investment Advisors first reported a position in United Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's United Therapeutics position peaked at $24.3K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.